openPR Logo
Press release

Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insights 2017

10-25-2017 12:46 PM CET | Health & Medicine

Press release from: Arizton Advisory & Intelligence

Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insights 2017

Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insights 2017

The “Anaplastic Lymphoma Kinase (ALK) Inhibitors-Pipeline Insights 2017″ report provides a comprehensive analysis of ALK drug candidates currently undergoing clinical trials. It covers detailed drug profiles of potential ALK inhibitors across various clinical development phases including–discovery, pre-clinical, IND, Phase I, Phase II, Phase III and pre-registration. The report also includes the pipeline products’ clinical trial data along with information on other development activities, including technology, licensing, collaborations, acquisitions, funding, patent, and USFDA and EMA designations. It also assesses the pipeline ALK inhibitors by monotherapy, combination products, molecule type and route of administration. In addition to analysis on active pipeline molecules, the report also provides a detailed information about discontinued and dormant drugs.

View report: https://www.arizton.com/reports/pharma-pipeline-analysis/anaplastic-lymphoma-kinase-alk-inhibitors-pipeline-insights

The report profiles key players in developing potential ALK drug candidates. The company profile section provides details such as company overview, business overview, financial overview, product portfolio, business strategies, and recent developments.

Scope

Provides in-depth insights about active Anaplastic Lymphoma Kinase (ALK) inhibitors pipeline drug candidates

Offers an extensive pipeline product coverage with demarcation by various stages of development from NDA filings to discovery

Provides pipeline assessment by monotherapy, combination therapy products, and route of administration

Provides comparative analysis of key marketed and pipeline Anaplastic Lymphoma Kinase (ALK) inhibitors

Includes coverage of detailed pipeline drug profiles, which include product description, chemical information, MOA, licensors and collaborators, development partner

Analyzes key players involved in clinical research and development of the ALK inhibitors

Provides the coverage of key news related to ALK inhibitors, including major mergers and acquisitions and product development updates such as clinical trial progression updates and regulatory updates

Related reports

1)AKT Inhibitors - Pipeline Insights 2017

https://www.arizton.com/reports/pharma-pipeline-analysis/akt-inhibitors-pipeline

2) Bruton's Tyrosine Kinase (BTK) Inhibitors - Pipeline Insights 2017

https://www.arizton.com/reports/pharma-pipeline-analysis/brutons-tyrosine-kinase-btk-inhibitors-pipeline

About Arizton
Arizton – Advisory and Intelligence is an innovation and quality-driven firm, which offers cutting-edge research solutions to clients across the world. We excel in providing comprehensive market intelligence reports and advisory and consulting services.

Arizton has gained a paramount standpoint in the market research arena as it offers top of the line solutions to clients to assess market landscape and to finalize foolproof business strategies. We are committed to provide inclusive market research reports and consulting services to clients from diversified industries including –Consumer Goods & Retail Technology, Automotive and Mobility, Smart Tech, Healthcare and Lifesciences, Industrial Machinery, Chemicals and Materials, IT and Media, Logistics and Packaging

Arizton comprises a team of exuberant and well-experienced analysts who have mastered in generating incisive reports. Our specialist analysts possess exemplary skills in market research. We train our team in advanced research practices, techniques, and ethics to outperform in fabricating impregnable research reports.

Arizton Advisory & Intelligence
Chicago, Illinois, 60605
Mail: enquiry@arizton.com
Call: +1-312-465-7864

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insights 2017 here

News-ID: 785302 • Views:

More Releases from Arizton Advisory & Intelligence

The Ventilators Market to Reach $2.56 Billion by 2029- Exclusive Focus Insight Report by Arizton
The Ventilators Market to Reach $2.56 Billion by 2029- Exclusive Focus Insight …
According to Arizton's latest research report, the global ventilators market is growing at a CAGR of 6.50% from 2023 to 2029. To Know More, Download the Free Sample Report: https://www.focusreports.store/report/ventilators-market-focused-insights Ventilators are vital to healthcare services, from hospitals to ambulatory healthcare services and homecare settings. The changing healthcare services in emerging markets and significant achieved development with developed countries consistently drive the ventilator market growth. There are some other conditions, such as
The U.S. Hair Wigs and Extensions Market to Reach USD 6.34 Billion by 2029 - Exclusive Focus Insight Report by Arizton
The U.S. Hair Wigs and Extensions Market to Reach USD 6.34 Billion by 2029 - Exc …
According to Arizton's latest focus research report, the U.S. hair wigs and extensions market is growing at a CAGR of 14.69% during 2024-2029. To Know More, Click: https://www.focusreports.store/report/us-hair-wigs-and-extensions-market-focused-insights In the US hair wigs & extensions market, the trend of natural hair wigs & extensions is gaining traction due to their realistic appearance. Halloween parties and cosplays further drive the demand for a variety of hair wigs with vibrant colors and textures.
The U.S. Water Filter Market to Reach USD 5.36 Billion by 2028 - Exclusive Focus Insight Report by Arizton
The U.S. Water Filter Market to Reach USD 5.36 Billion by 2028 - Exclusive Focus …
According to Arizton's latest research report, the U.S. water filter market is growing at a CAGR of 6.05% during 2023-2028. To Know More, Download the Free Sample Report: https://www.focusreports.store/report/us-water-filter-market-focused-insights The US water filter market is marked by a fiercely competitive landscape where various manufacturers and brands vie for consumer attention. One of the primary drivers of competition is innovation. Companies continually invest in research and development to improve filtration technology and product
The Sale of Construction Equipment in Latin America to Reach 145,985 Units by 2029 - Arizton
The Sale of Construction Equipment in Latin America to Reach 145,985 Units by 20 …
According to the latest research report, the Latin America construction equipment market is growing at a CAGR of 3.43% during 2023-2029. To Know More, Click: https://www.arizton.com/market-reports/latin-america-construction-equipment-market Brazil stands as the premier hub within the Latin American market, commanding a formidable 40% share of construction equipment sales across the region in 2023. Notably, it serves as the epicenter for manufacturing construction equipment on the continent, with all significant OEMs establishing manufacturing

All 5 Releases


More Releases for ALK

Epinephrine Market 2017 - Pfizer, Mylan, Sanofi, ALK Abello, Hospira
Apex Market Reports, recently published a detailed market research study focused on the "Epinephrine Market" across the global, regional and country level. The report provides 360° analysis of "Epinephrine Market" from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global Epinephrine industry, and estimates the future trend of Epinephrine market on the basis of
Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insights 2017
The “Anaplastic Lymphoma Kinase (ALK) Inhibitors-Pipeline Insights 2017″ report provides a comprehensive analysis of ALK drug candidates currently undergoing clinical trials. It covers detailed drug profiles of potential ALK inhibitors across various clinical development phases including–discovery, pre-clinical, IND, Phase I, Phase II, Phase III and pre-registration. The report also includes the pipeline products’ clinical trial data along with information on other development activities, including technology, licensing, collaborations, acquisitions, funding, patent,
Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insights 2017
The “Anaplastic Lymphoma Kinase (ALK) Inhibitors-Pipeline Insights 2017″ report provides a comprehensive analysis of ALK drug candidates currently undergoing clinical trials. It covers detailed drug profiles of potential ALK inhibitors across various clinical development phases including–discovery, pre-clinical, IND, Phase I, Phase II, Phase III and pre-registration. The report also includes the pipeline products’ clinical trial data along with information on other development activities, including technology, licensing, collaborations, acquisitions, funding, patent,
Anaplastic Lymphoma Kinase (ALK) Inhibitors - Pipeline Insights 2017
The “Anaplastic Lymphoma Kinase (ALK) Inhibitors-Pipeline Insights 2017″ report provides a comprehensive analysis of ALK drug candidates currently undergoing clinical trials. It covers detailed drug profiles of potential ALK inhibitors across various clinical development phases including–discovery, pre-clinical, IND, Phase I, Phase II, Phase III and pre-registration. The report also includes the pipeline products’ clinical trial data along with information on other development activities, including technology, licensing, collaborations, acquisitions, funding, patent,
GLOBAL EPINEPHRINE AUTOINJECTOR MARKET- MYLAN, SANOFI, ALK, ABELLO, IMPAX
Global Industry Study Evaluate on Epinephrine Autoinjector Market by Type, Manufacturers, Regions, and Application, Forecast up to 2022 The scope of the Epinephrine Autoinjector Report: This report primarily focuses on Epinephrine Autoinjector in the global market. This report generally covers Epinephrine Autoinjector market in North America, Epinephrine Autoinjector market in Asia-Pacific, Epinephrine Autoinjector market in Europe, Epinephrine Autoinjector market in Latin America, Middle as well as Africa. This report partitions the Epinephrine
Global Epinephrine Autoinjector Market 2017 - Mylan, Impax, Sanofi, ALK Abello
An epinephrine autoinjector is a medical device for injecting a measured dose or doses of epinephrine (adrenaline) by means of autoinjector technology. It is most often used for the treatment of anaphylaxis. The first epinephrine autoinjector was brought to market in the 1980s. Major players in the global Epinephrine Autoinjector market :- 1 Mylan (USA) 2 Impax (USA) 3 Sanofi (France) 4 ALK Abello (Denmark) Request for sample @ https://goo.gl/inqVd7 This report provides detailed analysis of